Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07298369 · ClinicalTrials.gov registry record · NA

Cracking Consciousness Study With Monroe & Neuphoria (Cohort 2&3)

A NA study of Mental Health, sponsored by Efforia.

Recruiting
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT07298369: Recruiting NA study of Mental Health, sponsored by Efforia.

NCT07298369 is a NA study of Mental Health that is actively recruiting participants, run by Efforia. The registered enrollment target is 100 participants, below the 10,182-participant average among 62 other Mental Health trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07298369, a NA study of Mental Health, is actively recruiting participants, sponsored by Efforia.

RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

In partnership with Monroe, this EEG neurofeedback study is looking at the efficacy of Neuphoria with Monroe for mental clarity and well-being.

Primary Outcome

Electroencephalography (EEG) will be used to quantify spectral power across standard frequency bands (delta \[1-4 Hz\], theta \[4-8 Hz\], alpha \[8-12 Hz\], beta \[12-30 Hz\]). Power values will be derived using proprietary signal processing algorithms and summarized as relative power per band.

Conditions Studied

Interventions

  • DEVICE Neuphoria Wearable

Study Locations (1)

New York

  • Efforia - New York

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2025-09-25
Est. Completion 2026-09-25
Phase NA
Efforia

19 total trials

What NCT07298369 shows while recruiting

NCT07298369 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 10,182-participant average among 62 other Mental Health trials with a reported enrollment target (99% lower).

The record links to 1 condition, with Mental Health appearing as the primary indexed condition, and to 1 intervention - of which Neuphoria Wearable is the first listed.

NCT07298369 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT07298369 about?

NCT07298369 is a clinical study titled "Cracking Consciousness Study With Monroe & Neuphoria (Cohort 2&3)". In partnership with Monroe, this EEG neurofeedback study is looking at the efficacy of Neuphoria with Monroe for mental clarity and well-being.

What is the current status of trial NCT07298369?

This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2025-09-25. Estimated completion is 2026-09-25.

What conditions does trial NCT07298369 study?

This clinical trial studies the following conditions: Mental Health.

What interventions are being tested in trial NCT07298369?

The interventions under investigation include: Neuphoria Wearable (DEVICE).

Who is sponsoring clinical trial NCT07298369?

This trial is sponsored by Efforia, which has 19 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07298369 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Mental Health

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07298369's enrollment target sits among peer trials

100 48th of 62 higher than 13 of 62 other Mental Health trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Mental Health trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07298369, the US trial registry maintained by the National Library of Medicine. NCT07298369 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.